ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 52.92% of PIRS shares are held by financial institutions. BVF INC/IL is the top corporate investor, holding 20.61M shares valued at $3.78M. A 20.83% stake in Pieris Pharmaceuticals, Inc. is owned by the company. LYNX1 CAPITAL MANAGEMENT LP owns 8.78M shares valued at $1.61M, which translates its holding of 8.87% of the stake in the company.
Among the PIRS insiders holding of 0.07% of the stake in company, AQUILO CAPITAL MANAGEMENT, LLC, 10 percent owner, holds the largest shares of 3.68M. BVF PARTNERS L P/IL, 10 percent owner, is the second largest PIRS insider with ownership of 314.14K shares. KHUONG CHAU QUANG, , stands third with possession of 65.4K shares of that stake.